Tektite Genome
Long Beach
About Tektite Genome
Tektite Genome is an innovation-driven brand dedicated to developing and commercializing non-toxic technologies that reshape the frontiers of biomolecular research, nanomanufacturing, and sustainable solutions. By uniting expertise in molecular analytics, advanced materials, and systems engineering, we deliver turnkey platforms’from AI-enhanced assay development to modular, high-throughput production lines’that empower partners across pharmaceuticals, environmental services, and green chemistry to accelerate discovery, ensure regulatory compliance, and optimize cost-efficiency. Our core capabilities span: • Biomolecular Research & AI Integration • Proprietary machine-learning models for real-time contaminant profiling, adaptive protocol refinement, and accelerated molecule design. • Automated “Genome Cleaner™” workflows for precision editing, quality control, and digital audit trails in GMP/GLP environments. • Nano-Manufacturing & Liquid Formulations • Scalable micro- and nano-fabrication processes for next-generation sensors, targeted delivery vehicles, and smart colloidal systems. • Custom liquid formulations engineered for enhanced stability, bioavailability, and eco-compatibility. • Ocean-Focused Sustainable Solutions • Bio-remediation strategies and biosensor arrays for in-situ monitoring of marine ecosystems and industrial effluents. • Marine-derived nanoparticle synthesis for eco-friendly materials, carbon sequestration, and circular-economy applications. • Particle Research & Advanced Materials • High-resolution characterization and engineering of particulate systems for catalysis, energy storage, and next-generation semiconductors. Backed by institutional collaborations and poised for strategic deployments - Tektite Genome is uniquely positioned to deliver the safe, scalable technologies that will define tomorrow’s industries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.0M
- Funding stage: IPO
- Last round: Angel (Jun 2023)
- Website: tektitegenome.comschedule-treatment
- Phone: +1 800-916-8106
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics, Predictive Analytics, Robotics
Social Profiles
Canonical: https://fsome.com/organization/tektite-genome-100569 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.